Get startedLog in
    Picture of Quoin Pharmaceuticals logo

    QNRX — Quoin Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Cellect Biotechnology Initiates U.S. Clinical Trial Of Apograft

    Picture of Quoin Pharmaceuticals logoQuoin Pharmaceuticals
    22/10/2020 13:09
    Oct 22 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY INITIATES U.S. CLINICAL TRIAL OF
APOGRAFT
    * CELLECT BIOTECHNOLOGY LTD - INITIATED CLINICAL TRIAL IN
U.S. TO
DETERMINE SAFETY &TOLERABILITY OF APOGRAFT TECHNOLOGY FOR BONE
MARROW TRANSPLANTATIONS
    * CELLECT BIOTECHNOLOGY LTD - TRIAL WILL ENROLL 18 PATIENTS

Source text for Eikon:  ID:nGNX64VRND 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Quoin Pharmaceuticals

    See all news